Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Eosinophilic Gastroenteritis: full-pipeline trial registry
2 of 6 indexed Eosinophilic Gastroenteritis trials are currently recruiting.
Corpus placement: #2,866 of 28,707 conditions by registered trial count.
6 US clinical trials · 2 currently recruiting · #2,866 of 28,707 conditions by registered trial count
Eosinophilic Gastroenteritis: 6 US clinical trials tracked, 2 recruiting.
Eosinophilic Gastroenteritis is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Allakos, running 2 of these trials.
Enrollment posture brief
Registry condition eosinophilic-gastroenteritis
OPEN 2 | RECR 33% | LATE 2 | EARLY 2 | RANK #2866 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Adherence, Treatment (33% recruiting · 6 trials)
Eosinophilic Gastroenteritis lists 2 open slots (33% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Eosinophilic Gastroenteritis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Eosinophilic Gastroenteritis is recruiting below its size-band peers.
2 of 6 indexed trials (33.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Eosinophilic Gastroenteritis research.
Allakos accounts for 2 of 6 trials (33.3%). 5 distinct sponsors appear on at least one study for this condition label.
-
Most Eosinophilic Gastroenteritis trials plan to enrol fewer than 100 people.
Median target enrolment is 94 among the 6 trials that report a genuine target (sentinel values excluded). 4 of those (66.7%) plan for fewer than 100 participants.
-
Eosinophilic Gastroenteritis splits between interventional and observational designs.
4 interventional and 2 observational studies make up this index (66.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
6 total, page 1 of 1
OMEGA: Outcome Measures in Eosinophilic Gastrointestinal Disorders Across the Ages
Children's Hospital Medical Center, Cincinnati
NCT02523118
Eosinophilic Gastrointestinal Disorders Registry
Ann & Robert H Lurie Children's Hospital of Chicago
NCT05199532
A Study to Learn How Well Dupilumab Works in Adult and Adolescent Participants With Eosinophilic Gastritis With or Without Eosinophilic Duodenitis and the Side Effects it May Have
Regeneron Pharmaceuticals
NCT05831176
A Study of Lirentelimab (AK002) in Patients With Active Eosinophilic Duodenitis
Allakos
NCT04856891
An Extension Study of AK002 in Patients With Eosinophilic Gastritis and/or Eosinophilic Duodenitis
Allakos
NCT03664960
Examining the Effect of Ondansetron on Bowel Prep Success
State University of New York - Downstate Medical Center
NCT05439772
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 2 |
| Phase 3 | 1 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Eosinophilic Gastroenteritis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Eosinophilic Gastroenteritis trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Eosinophilic Gastroenteritis page
6 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Eosinophilic Gastroenteritis trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Allakos sponsors the most Eosinophilic Gastroenteritis trials on record, review their full trial history before evaluating a specific study. See Allakos's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Eosinophilic Gastroenteritis condition card totals 6 registered trials; most-linked intervention AK002; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.